ID

22131

Beschrijving

Study part: 60 Days Post- Treatment Concomitant medications. A phase III multinational, randomized, single-blind study of recombinant humanized anti-p185HER2 monoclonal antibody (rhuMAb HER2) in patients with HER2/neu overexpression who have not received prior cytotoxic chemotherapy for metastatic breast cancer. "Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche"

Trefwoorden

Versies (2)
  1. 20-05-17 20-05-17 -
  2. 15-03-21 15-03-21 - Dr. rer. medic Philipp Neuhaus
Houder van rechten

Roche

Geüploaded op

20 mei 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

60 DAYS POST-TREATMENT CONCOMITANT MEDICATIONS Roche H0650g Breast Cancer

Engels

60 DAYS POST-TREATMENT CONCOMITANT MEDICATIONS

1 Formulieren  
CONCOMITANT MEDICATIONS
Beschrijving

CONCOMITANT MEDICATIONS

Alias
UMLS CUI-1
C2347852
PATIENT INT.
Beschrijving

Patient initial

Datatype

text

Alias
UMLS CUI [1]
C2986440
PATIENT NUMBER
Beschrijving

Patient id

Datatype

integer

Alias
UMLS CUI [1]
C2348585
DRUG NAME
Beschrijving

concomitant medication

Datatype

text

Alias
UMLS CUI [1]
C2347852
INDICATION- PROPHYLAXIS ?
Beschrijving

Prophylaxis Indication medication

Datatype

boolean

Alias
UMLS CUI [1,1]
C0199176
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0013227
INDICATION
Beschrijving

Indication medication

Datatype

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0013227
TOTAL DAILY DOSE- PRN ?
Beschrijving

TOTAL DAILY DOSE

Datatype

boolean

Alias
UMLS CUI [1]
C2348070
TOTAL DAILY DOSE (units)
Beschrijving

TOTAL DAILY DOSE

Datatype

float

Alias
UMLS CUI [1]
C2348070
DATE OF FIRST DOSE
Beschrijving

therapy start date

Datatype

date

Alias
UMLS CUI [1]
C1531783
FIRST DOSE- CONTINUING?
Beschrijving

CONCOMITANT MEDICATIONS

Datatype

boolean

Alias
UMLS CUI [1]
C2347852
DATE OF FINAL DOSE
Beschrijving

therapy end date

Datatype

date

Alias
UMLS CUI [1]
C1531784
FINAL DOSE- ONGOING?
Beschrijving

CONCOMITANT MEDICATIONS

Datatype

boolean

Alias
UMLS CUI [1]
C2347852
Terug naar het begin van de pagina

Similar models

60 DAYS POST-TREATMENT CONCOMITANT MEDICATIONS

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
CONCOMITANT MEDICATIONS
C2347852 (UMLS CUI-1)
Patient initial
Item
PATIENT INT.
text
C2986440 (UMLS CUI [1])
Patient id
Item
PATIENT NUMBER
integer
C2348585 (UMLS CUI [1])
concomitant medication
Item
DRUG NAME
text
C2347852 (UMLS CUI [1])
Prophylaxis Indication medication
Item
INDICATION- PROPHYLAXIS ?
boolean
C0199176 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Indication medication
Item
INDICATION
text
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
TOTAL DAILY DOSE
Item
TOTAL DAILY DOSE- PRN ?
boolean
C2348070 (UMLS CUI [1])
TOTAL DAILY DOSE
Item
TOTAL DAILY DOSE (units)
float
C2348070 (UMLS CUI [1])
therapy start date
Item
DATE OF FIRST DOSE
date
C1531783 (UMLS CUI [1])
CONCOMITANT MEDICATIONS
Item
FIRST DOSE- CONTINUING?
boolean
C2347852 (UMLS CUI [1])
therapy end date
Item
DATE OF FINAL DOSE
date
C1531784 (UMLS CUI [1])
CONCOMITANT MEDICATIONS
Item
FINAL DOSE- ONGOING?
boolean
C2347852 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial